Indutrade acquires the cleanroom product specialist Miclev

Indutrade has signed an agreement to acquire all shares in the Swedish company Miclev Medical Products AB, www.miclev.se/en, with annual sales of approximately SEK 130 million.

Miclev is a technical trading company specialised in high-quality products for detecting, identifying, eliminating, and protecting against microorganisms. The product offering includes culture media, diagnostic products, and consumables for safe microbiological processes in sterile cleanroom environments with high quality requirements, for the Nordic pharmaceutical and biotech industries. Miclev was founded in 1996, has 12 employees and is located in Malmö, Sweden.

“Miclev is a great addition to our group of life science companies. They have a strong product offering and high level of customer service, which in combination with very deep technical expertise and underlying market growth paves the way for continued sustainable, profitable growth”, said Bo Annvik, President and CEO of Indutrade.

The closing takes place today and Miclev will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's twelfth in 2024 and is expected to have a marginally positive impact on Indutrade's earnings per share.  

Stockholm, 2 July 2024

INDUTRADE AB (publ)

For further information, please contact:
Bo Annvik, President and CEO
Phone +46 8 703 03 00

About Indutrade
Indutrade is an international technology and industrial business group that today consists of approximately 200 companies in some 30 countries, mainly in Europe. In a decentralised way, we aim to provide sustainable profitable growth by developing and acquiring successful companies managed by passionate entrepreneurs. Our companies develop, manufacture, and sell components, systems and services with significant technical content in selected niches. Our value-based culture, where people make the difference, has been the foundation of our success since the start in 1978. Indutrade's net sales totalled SEK 32 billion in 2023, and the share is listed on Nasdaq Stockholm in Sweden.